Antibiotic shots, whether injected into muscle or delivered through a vein, are used when an infection is too severe for pills, when the gut cannot reliably absorb a drug, or when a single powerful dose is the most practical treatment. They work faster and more predictably than oral antibiotics because the medication enters the bloodstream directly, but that speed comes with a trade-off: injection-site pain, a small risk of allergic reactions, and, depending on the drug, effects on the kidneys, ears, or gut. The reasons a doctor reaches for a needle instead of a prescription pad vary widely, and so do the side effects you should watch for.
Why a Shot Instead of a Pill
Most infections can be treated with oral antibiotics, and in outpatient settings, pills are the norm. The injection route becomes necessary when conditions demand it. Someone vomiting or with severe diarrhea cannot keep a pill down long enough for it to be absorbed. A critically ill patient in the hospital needs drug levels in the blood to climb as fast as possible, not wait an hour or two for a tablet to dissolve. And certain antibiotics simply do not come in oral form, or their oral versions are absorbed so poorly that injecting them is the only way to get adequate drug concentrations where the infection lives.
There is also a compliance factor. A single intramuscular shot of an antibiotic given in a clinic guarantees the patient received the full dose. With a ten-day course of pills, there is always the chance someone stops early because they feel better, breeding resistant bacteria in the process. In the United States, close to a third of outpatient antibiotic prescriptions are unnecessary to begin with, and the selection or duration is often inappropriate even when an antibiotic is warranted.1PubMed. Advances in optimizing the prescription of antibiotics in outpatient settings Against that backdrop, a one-and-done shot can be a simpler path to correct treatment.
Cultural expectations also play a role. Research into why hospitals default to intravenous antibiotics even when oral options exist has found that doctors sometimes view IV drugs as having an almost “mythical” extra potency, a perception they themselves admit is not always evidence-based. Concerns about patient complaints or litigation also push clinicians toward the IV route, since patients and families sometimes equate a drip with serious, attentive care.2Journal of Antimicrobial Chemotherapy. What prevents the intravenous to oral antibiotic switch? A qualitative study of hospital doctors’ accounts of what influences their clinical practice Patients themselves can be skeptical that an oral antibiotic works as well as an injected one, which creates reluctance to switch even when the evidence supports it.3BMC Infectious Diseases. Inpatients’ willingness to accept antibiotic intravenous-to-oral switch therapy and its influencing factors: a qualitative study based on the Health Belief Model
The Most Common Antibiotic Shots and What They Treat
A handful of injectable antibiotics account for the vast majority of shots you will encounter in clinics, emergency rooms, and hospitals. Knowing which one you received helps you understand what side effects to expect.
Ceftriaxone is probably the injectable antibiotic most people will meet. It belongs to the cephalosporin family and is given as a single intramuscular shot for gonorrhea (typically 500 mg), as well as for certain urinary tract infections, pelvic inflammatory disease, and some cases of epididymitis or proctitis, usually paired with an oral antibiotic like doxycycline.4Emergency Medicine Clinics of North America. Sexually Transmitted Infections in the Emergency Department In hospital settings, short courses of intravenous ceftriaxone, sometimes as few as three days, have been studied for uncomplicated urinary tract infections with outcomes comparable to longer courses.5PubMed Central. Three-day ceftriaxone versus longer durations of therapy for inpatient treatment of uncomplicated urinary tract infection
Benzathine penicillin G (BPG) is the go-to shot for syphilis and for preventing recurrences of rheumatic fever. It is a thick, slow-absorbing formulation injected deep into the gluteal muscle. The viscosity of BPG makes it one of the more painful antibiotic injections, a fact that has prompted a meaningful amount of research into ways to make it more tolerable.
Aminoglycosides such as gentamicin and tobramycin are reserved for serious gram-negative infections and are almost always given intravenously in a hospital. They are powerful but carry specific risks to the kidneys and inner ear that other injectable antibiotics do not, which is why their blood levels are closely monitored.
Pain at the Injection Site
The most immediate and universal effect of an antibiotic shot is pain where the needle goes in. The severity depends on the drug, the volume injected, and the injection technique. BPG is thick enough that it hurts considerably more than, say, a ceftriaxone shot. Some patients describe the BPG injection as one of the most painful medical experiences they have had, which is a real barrier to treatment adherence for people who need repeat doses (syphilis in later stages requires three weekly injections, and rheumatic fever prophylaxis can continue for years).
Mixing a local anesthetic like lidocaine into the BPG syringe before injection significantly reduces pain. A systematic review found that lidocaine mixed with BPG cut immediate post-injection pain by roughly four points on a ten-point scale, and the benefit was still measurable at five and twenty minutes after the shot.6The Lancet. Local anaesthetic to reduce injection pain in patients who are prescribed intramuscular benzathine penicillin G: a systematic review and meta-analysis Applying a lidocaine cream to the skin beforehand, however, did not help much. If you are due for a BPG shot and are worried about pain, asking your provider about lidocaine mixed into the injection is reasonable and evidence-backed.
For other intramuscular antibiotic injections, applying a vibrating device to the skin near the injection site has shown promise. In a randomized trial of patients receiving intramuscular antibiotic injections in an emergency department, local vibration reduced perceived pain and improved satisfaction more than a placebo device or no intervention.7PubMed Central. Effectiveness of Two Different Methods on the Perceived Pain and Satisfaction During Intramuscular Antibiotic Injection: ShotBlocker and Local Vibration These devices work on the “gate control” principle: overwhelming the nerve with vibration sensations makes it harder for the brain to register the sharp pain of the needle.
Allergic Reactions and Anaphylaxis
Allergic reactions are the most feared complication of any antibiotic, and injectable antibiotics carry the same risk as oral ones, sometimes slightly higher because the drug reaches the bloodstream faster. Penicillin-family drugs get the most attention. True anaphylaxis from penicillin occurs in roughly 1 to 5 out of every 10,000 treatment courses.8PubMed Central. The facts about penicillin allergy: a review That is uncommon but not negligible, which is why clinics that give antibiotic shots keep epinephrine on hand and ask you to wait for at least 15 to 30 minutes afterward.
An immediate allergic reaction typically shows up within one to two hours as an itchy widespread rash, facial swelling, wheezing, or a drop in blood pressure. An “accelerated” reaction can appear between two and six hours after the dose with similar symptoms.9Journal of Antimicrobial Chemotherapy. Antimicrobial anaphylaxis: the changing face of severe antimicrobial allergy If you develop any of these after leaving the clinic, seek emergency care immediately.
Many people who believe they are allergic to penicillin actually are not. The label often gets attached after a childhood rash that may have been caused by the illness rather than the drug, and true IgE-mediated penicillin allergy fades over time in most people. A recent study tested cefuroxime, a cephalosporin antibiotic related to penicillin, in surgical patients who had a documented history of penicillin allergy using a structured safety algorithm. None of them had an allergic reaction.10PubMed Central. Single-Shot Perioperative Antibiotic Prophylaxis in Patients With a History of Penicillin Allergy: An Algorithm for the Safe Administration of Cefuroxime This does not mean you should ignore a penicillin allergy label, but it suggests that formal allergy testing can safely open up treatment options that were previously off the table.
Effects on the Gut
Any antibiotic, oral or injected, can disrupt the balance of bacteria in your intestines. The most serious consequence of that disruption is an overgrowth of Clostridioides difficile, a bacterium that causes severe, sometimes life-threatening diarrhea. Injected antibiotics are not inherently worse than oral ones for this; the risk depends on which drug you receive, how long the course lasts, and your individual susceptibility.
Among antibiotics commonly given by injection, later-generation cephalosporins (including ceftriaxone), fluoroquinolones, and carbapenems carry higher risk for C. difficile infection.11PubMed Central. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection In one hospital study, piperacillin-tazobactam (a broad-spectrum IV antibiotic) was the drug most commonly associated with C. difficile cases, followed by carbapenems, with ceftriaxone implicated in about 16% of cases.12PubMed Central. Antibiotics Associated With Clostridium difficile Infection In the community setting, clindamycin carried the highest odds of C. difficile infection, while doxycycline and tetracycline showed no statistically significant increase in risk.13PubMed Central. Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study
The practical takeaway: a single shot of ceftriaxone for gonorrhea is a very different exposure from a week of IV ceftriaxone in the hospital. Short, targeted courses carry far less gut disruption than prolonged broad-spectrum regimens. If you are receiving IV antibiotics in the hospital for more than a few days, watch for watery diarrhea, abdominal cramping, or fever, and report these symptoms promptly.
Kidney and Hearing Damage From Aminoglycosides
Aminoglycosides like gentamicin and tobramycin sit in a category of their own when it comes to potential harm. These drugs are exceptionally effective against certain resistant infections, but they can damage the kidneys and the sensory hair cells of the inner ear. The kidney injury happens because the drug accumulates in the cells lining the kidney’s filtering tubes, disrupting normal cellular cleanup processes.14PubMed. Aminoglycoside-Related Nephrotoxicity and Ototoxicity in Clinical Practice: A Review of Pathophysiological Mechanism and Treatment Options The hearing damage occurs because the drug enters the delicate hair cells of the cochlea and triggers the production of destructive molecules that kill those cells. Unlike kidney damage, which is often reversible if caught early, hearing loss from aminoglycosides tends to be permanent.
Certain genetic variants make some people dramatically more susceptible to aminoglycoside-related hearing loss. Mutations in mitochondrial DNA, particularly in a gene called 12S rRNA, can make even a single dose dangerous to hearing.15PubMed Central. Mechanism and Prevention of Ototoxicity Induced by Aminoglycosides Exposure during pregnancy can also cause permanent hearing damage in the developing fetus. For these reasons, aminoglycosides are monitored with frequent blood tests to ensure drug levels stay within a safe range, and they are generally reserved for infections where safer alternatives have failed.
Nerve Injury From Injection
An underappreciated risk of intramuscular antibiotic shots is nerve damage from a misplaced needle. The sciatic nerve, which runs through the buttock, is the most commonly injured nerve during gluteal injections. Consequences range from brief tingling or pain to severe, lasting sensory loss and difficulty moving the leg.16PubMed. Sciatic nerve injection injury Children, elderly patients, and underweight individuals are at higher risk because they have less muscle and fat to cushion the nerve.
This is not an exotic complication confined to under-resourced settings. Case reports describe it across healthcare systems worldwide, including in well-equipped hospitals.17PubMed Central. Iatrogenic Injury to the Sciatic Nerve due to Intramuscular Injection: A Case Report 18PubMed. Sciatic nerve injury from intramuscular injection: a persistent and global problem Modern best practice uses the ventrogluteal site (the side of the hip) rather than the traditional dorsogluteal site (the upper outer buttock) because the sciatic nerve is further away. If you are receiving an intramuscular antibiotic and the provider targets the side of your hip rather than the back of your buttock, that is a good sign they are following current guidelines.
When IV Antibiotics Get Switched to Pills
If you are hospitalized and started on IV antibiotics, the goal is usually to switch you to an equivalent oral drug as soon as it is safe. This is not a downgrade in care. Oral versions of many antibiotics reach blood levels comparable to their IV counterparts once the gut is working normally, and the switch eliminates the risks that come with an IV line, including bloodstream infections from the catheter itself.
The criteria for switching are straightforward: you have been on IV therapy for at least 48 hours, you are improving clinically (temperature normalizing, vital signs stable), you are not vomiting, and you can swallow pills.19PubMed Central. Practice of switch from intravenous to oral antibiotics When hospitals have introduced formal guidelines to encourage this switch, the results have been encouraging. One large teaching hospital found that about 40% of patients started on IV antibiotics were candidates for an early oral switch. After implementing guidelines, the proportion who actually got switched rose from 54% to 83%, and the timing improved too: from a median of six days on the IV to four. Crucially, there were no infection recurrences or readmissions in the weeks that followed.20Journal of Antimicrobial Chemotherapy. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital
Despite this evidence, many patients remain on IV antibiotics longer than necessary. Some of the reluctance comes from the perception that IV drugs are inherently stronger. For patients who are critically ill or unable to absorb oral medications, IV therapy remains essential.21PubMed Central. Switch over from intravenous to oral therapy: A concise overview But for the rest, pushing for an oral switch when you meet the clinical criteria is not cutting corners. It is evidence-based medicine.
Getting IV Antibiotics at Home
Some infections, particularly bone infections, heart valve infections, and deep abscesses, require weeks of IV antibiotics. Keeping someone in the hospital for that entire course is expensive and unpleasant. Outpatient parenteral antibiotic therapy, known as OPAT, allows patients to receive their IV doses at home or at an infusion center while going about their daily lives.
The cost savings are substantial. A UK analysis found that OPAT cost roughly 41% to 61% of what equivalent inpatient treatment would have cost, depending on the comparison used.22PubMed. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective Another study of patients with infective endocarditis, a condition that historically required prolonged hospitalization, showed that selected patients could safely complete their IV antibiotic courses at home, saving an average of about 22 hospital bed-days per patient.23PubMed Central. Outpatient parenteral antimicrobial therapy (OPAT) service is associated with inpatient-bed cost savings OPAT is not appropriate for everyone: you need to be stable enough, have a reliable home environment, and be able to manage or have help with the infusion equipment. But for the right patient, it is a genuine improvement in quality of life during what would otherwise be a long hospital stay.
Supply Shortages of Injectable Antibiotics
One issue that does not get enough public attention is that some of the most important injectable antibiotics are periodically unavailable. Benzathine penicillin G, the only recommended treatment for syphilis in pregnancy and the primary weapon against rheumatic heart disease recurrence, has experienced widespread global shortages. Surveys across multiple countries have documented that these stockouts compromise treatment of adult syphilis, prevention of congenital syphilis in newborns, and management of other conditions for which BPG is the standard of care.24PLOS Medicine. Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: An evaluation from multi-country surveys and stakeholder interviews
The reasons are partly economic. BPG is an old, inexpensive drug with thin profit margins, so few manufacturers produce it, and any disruption at a single factory can ripple globally. For patients, this can mean delayed treatment or substitution with less ideal alternatives. If you are being treated for syphilis and your provider mentions difficulty obtaining the standard medication, this is the context behind that conversation.
Microneedle Patches and What Comes Next
The traditional hypodermic needle may not be the only option for much longer. Microneedle patches, which look like small adhesive bandages studded with hundreds of tiny projections barely visible to the naked eye, have been under active development for drug delivery over the past decade. These patches penetrate just the outermost layer of skin, enough to deliver medication into the body without reaching the deeper nerve endings that make conventional injections painful.25PubMed Central. Application of microneedle patches for drug delivery; doorstep to novel therapies
For antibiotics, microneedle delivery could be transformative in settings where trained personnel for injections are scarce or where needle-phobia leads patients to skip treatment. The technology is still largely in the research phase for antibiotic applications, and getting large drug doses through a patch remains an engineering challenge. But the trajectory is clear: the future of injectable antibiotics may involve no needle at all, just a patch you press onto your arm for a few minutes. For the millions of people worldwide who need repeated BPG injections for rheumatic fever prophylaxis and dread every one of them, that future cannot arrive soon enough.